Business Wire

SailPoint Awarded U.S. Patent for Securely Managing Identities from the Cloud

22.3.2017 11:00 | Business Wire

Del

SailPoint, the leader in identity management, today announced that the U.S. Patent and Trademark Office has recognized SailPoint’s innovative approach to empowering enterprise employee and partner populations to manage their network access credentials, even when located remotely and locked out of the corporate network. This new patent award enables SailPoint to uniquely provide a solution that ensures security for the enterprise and ease of use for both remote workers and office-based employees and partners. SailPoint’s patent number 9,600,656, entitled ‘System and Method for Domain Password Reset in a Secured Distributed Network Environment’, is another example of the company’s innovative approach to securing identity data for global enterprises.

Typically, company-issued laptops and other mobile devices don’t allow users to recover from forgotten network passwords while away from the office and disconnected from the company domain servers. This presents a challenge to anyone who works remotely or travels as part of their job responsibilities. Should they happen to forget their network password while disconnected from the corporate network, until now there has been no way to reset the password without employing duplicate local accounts or physically connecting the device to the main company domain server and network. In this situation, remote employees are effectively locked out and must ship their laptop to the company's IT staff so they can reset the password and then ship it back. In the case of the business traveler, they must wait until they return from their business trip to re-attach to the corporate domain server. This all leads to a significant loss in productivity and end-user dissatisfaction.

SailPoint’s patented technology enables remote business users to reset their local and domain password remotely without having to involve IT. This processes leverages SailPoint’s newly patented technology, and the SailPoint open identity platform, to create a seamless, secure and convenient end to end solution. Once reset, the user's password is automatically updated across the connected windows domain, eliminating any need for physical connectivity or the arcane shipment of hardware.

“Companies of all sizes need to ensure the security of remote workers without sacrificing productivity and ease of use,” said Darran Rolls, CTO of SailPoint. “This patented technology illustrates our continued focus on infusing innovation into our open identity platform to solve real-world issues that our customers face today. With this capability, when a remote worker needs to reset their password and they cannot connect to the corporate network, we can provide a simple convenient self-service solution that does require direct It involvement. This means cost savings, improved productivity and a better end-user experience.”

This new patent complements SailPoint’s existing patent portfolio which includes a “System and Method for Securing Authentication Information in a Networked Environment,” highlighting the uniquely differentiated way that SailPoint’s SaaS solution, IdentityNow, maintains no knowledge of the administrative credentials used to access enterprise resources located behind the firewall, ensuring that even in the case of a rogue employee in the data center, the customer’s infrastructure will remain secure.

SailPoint: The Power of Identity™

SailPoint, the leader in identity management, brings the Power of Identity to enterprise customers around the world. SailPoint’s open identity platform gives enterprises the power to enter new markets, scale their workforces, embrace new technologies, innovate faster and compete on a global basis – securely and confidently. The company pioneered and is the undisputed leader in identity governance, and provides an integrated set of cloud-based services, including compliance controls, provisioning, password management, single sign-on and data access governance, all built on the belief that identity is a business enabler. SailPoint's customers are among the world’s largest companies in virtually every industry, including: 9 of the top banks, 6 of the top 10 healthcare organizations, 6 of the top 20 property and casualty insurance providers, and 6 of the top 20 pharmaceutical companies.

Stay up-to-date on SailPoint by following us on Twitter and LinkedIn and by subscribing to the SailPoint blog.

SailPoint, the SailPoint logo, IdentityIQ, IdentityNow, SecurityIQ and all techniques are trademarks or registered trademarks of SailPoint Technologies, Inc. in the U.S. and/or other countries. All other products or services are trademarks of their respective companies.

Contact information

SailPoint
Jessica Sutera, 978-278-5411
Jessica.sutera@sailpoint.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

IFF to Present at the Barclays Global Consumer Staples Conference21.8.2017 20:15Pressemelding

Regulatory News: International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF), a leading innovator of sensory experiences that move the world, today announced that Andreas Fibig, Chairman and Chief Executive Officer will present at the Barclays Global Consumer Staples Conference in Boston, MA on Thursday, September 7, 2017 at 11:15 a.m. EDT. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Meet IFF International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF) is a leading innovator of sensorial experiences that move the world. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for explorati

Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform21.8.2017 20:11Pressemelding

Celularity, Inc., a newly formed biotechnology company, today announced its acceleration of cell and tissue regenerative therapies to address unmet medical needs in cancer and chronic and degenerative disease. Celularity completed their Series A financing with contributions from several biopharma companies, including Sorrento Therapeutics, United Therapeutics Corporation and Human Longevity, Inc., and entrepreneurial investors. Celularity has been created through the contributions of extensive intellectual property, clinical-stage assets, basic and clinical research, and development expertise including: Several clinical-stage immuno-oncology and regenerative medicine assets and a pipeline of pre-clinical assets Proprietary allogeneic (“readily accessible”) immunotherapy platform 200+ issued and pending patents in cell therapy

European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 13:25Pressemelding

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the

IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 12:00Pressemelding

IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman

PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 08:03Pressemelding

PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate

Glennmont Partners Completes Refinancing of Sleaford Biomass Plant for £150m21.8.2017 08:00Pressemelding

Glennmont Partners has successfully completed the refinancing of the Sleaford Renewable Energy Plant on behalf of its dedicated clean energy fund, Glennmont Clean Energy Fund Europe I, as part of a programme of realisations of value from the Fund. Glennmont Partners is one of Europe’s largest fund managers focusing exclusively on investment in clean energy infrastructure. Glennmont raises long-term capital to invest in alternative power generation projects including wind farms, biomass power stations, solar parks and small-scale hydro power plants. The carefully selected, risk managed investments deliver sustained performance and predictable returns over periods of 10 years or more. Sleaford REP is a 40MWe straw-fired biomass plant located in Lincolnshire, UK. The plant has been in operation since 2014 and is being operated by Burmeister & Wain Scandinavian Contractor (BWSC). The

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom